Temafloxacin (marketed by Abbott Laboratories as Omniflox) is a fluoroquinolone antibiotic drug which was withdrawn from sale in the United States shortly after its approval in 1992 because of serious adverse effects resulting in three deaths.
Temafloxacin (marketed as Omniflox) is a fluoroquinolone antibiotic that was removed from the market in the United States shortly after its release in 1992 due to severe adverse reactions, which ultimately led to three fatalities.